A collaboration of Binaytara Foundation and St. Joseph Regional Medical Center
Aug 10, 2013
Lewis-Clark State College, Williams Conference Center, 500 8th Avenue, Lewiston ID
Download Brochure (PDF)
Updates in Hematologic Malignancies – A multidisciplinary conference will have balanced educational sessions focusing on the needs of hematologists, oncologists, primary care physicians, nurses, pharmacists and other healthcare professionals involved in management of hematologic malignancies. Faculty will discuss current and emerging concepts in the field of hematologic malignancies.
1. Dr. Michael Rooney - Conference Chair
2. Dr. Binay Shah
3. Pamela Sly, RN
4. Pamela Reed, RN, BSN, OCN
5. Tamara Jones, RN
6. Paul Driver, PharmD
3. Primary Care providers (Internists, Family practioners, NP, PA)
6. Other healthcare professionals involved in management of hematologic malignancies (Social workers, physical therapists, nutritionists)
There have been several new developments in the field of hematologic malignancies. Five new drugs - ponatinib, omacetaxine, bosutinib, vinctistine - liposomal injection, carfilzomib were approved in 2012 and pomalidomide was approved in 2013 for treatment of hematologic malignancies. There is a need for educational sessions for healthcare providers involved in management of hematologic malignancies.
Physicians: USD 100 (until June 30, 2013), USD 125 (until August 9th, 2013) USD 150 (onsite)
RN/NP/PA/PharmD/Allied Health Professionals: USD 50 (June 30, 2013), USD 75 (until August 9th, 2013) USD 100 (onsite)
Please pay the registration fees by clicking on the button below. Once the transaction is completed, you will
be presented with the registration page. If you would like to pay by check, please complete the Registration Form, write a check to "Binaytara Foundation" and mail to:
At the conclusion of this activity, participants will be able to
a) recognize factors that affect the diagnosis, staging, and prognosis of patients with hematologic malignancies
b) explain indications and contraindications of treatments used for hematologic malignancies
c) discuss emerging therapeutic options for treating patients with hematologic malignancies with colleagues and patients
d) interpret new, practice relevant data presented at ASCO 2013
e) nurses will be able to provide appropriate care and counsel patients with hematologic malignancies and their families
1. Professor Damiano Rondelli, Chief of Hematology/Oncology, University of Illinois, Chicago
2. Professor Divyesh Mehta, Chief of Hematology/Oncology, Division at Maricopa Integrated Health System, Phoenix, AZ
3. Dr. Binay K Shah, Hematologist/Oncologist, St. Joseph Regional Medical Center
4. Dr. Edward Libby, Seattle Cancer Care Alliance
5. Sandra Cueller, PharmD, Assistant Professor, University of Illinois, Chicago
Dr. Edward Libby received his B.S. in Chemistry from theUniversity of Texas at El Paso and his M.D. from the University of Texas Health Science Center atHouston. He completed his Internal Medicine residency at the University of New Mexico(UNM) in Albuquerque and then completed training inHematology at UNM as well. At the University of New Mexico Dr Libby led the Hematologic Malignancies group and managed the stem cell transplant team from its inception. He then joined the Seattle Cancer Care Alliance to advance his research career and to focus exclusively in myeloma and lymphoma.
Sandra Cuellar, Pharm.D., BCOP, is a Clinical Assistant Professor in the Department of Pharmacy Practice at the University of Illinois at Chicago (UIC) College of Pharmacy. Dr. Cuellar has been active in the field of hematology/oncology for 10 years. She is the coordinator and clinical assistant professor for oncology therapeutics. Dr. Cuellar received her Bachelor of Liberal Arts from Augustana College in Rock Island, Illinois, followed by her Pharm.D. degree from the University of Illinois at Chicago College of Pharmacy. She then completed a Pharmacy Practice Residency at University of Kentucky Chandler Medical Center. Following her residency, she completed a specialty oncology residency at MD Anderson Cancer Center in Houston, Texas. She currently is the clinical pharmacist in the Out-Patient Cancer Center and is also the director of the oncology specialty residency program at UIC. Dr. Cuellar is an editor at large for Journal of Hematology Oncology Pharmacy and is involved in research, consulting and publications in the field of hematology/oncology.
Dr. Binay Shah is a hematologist and oncologist at
St. Joseph Regional Medical Center, Lewiston, Idaho. His clinical research
focusses on health services and outcomes. Dr. Shah has published a number of
papers in peer-reviewed journals including Journal of Clinical Oncology,
British Journal of Hematology, Leukemia and Lymphoma, Acta Hematologica,
Annals of Hematology. He has presented a number of research papers in national
and international conferences. He is a reviewer of many esteemed journals
including Annals of Internal Medicine, European Journal of Hematology,
Divyesh G. Mehta, MD is Professor Of Medicine
at University Of Arizona College Of Medicine and Chief of Hematology Oncology Division
at Maricopa Integrated Health System, Phoenix, AZ. Dr. Mehta is a Professor of
Medicine at University of Arizona College of Medicine. Dr. Mehta has research
interest in Triple Negative Breast Cancer and Multi modality treatment of
Dr. Damiano Rondelli is a Professor of Medicine
and Director of Stem Cell Transplant Program at the University of Illinois at Chicago.
This activity has been planned and implemented in accordance with the Essential Elements, Criteria, and Standards of Accreditation of the Idaho State Medical Association CME Accreditation Committee through the partnership of Gritman Medical Center and St Joseph Regional Hospital. Gritman Medical Center is an Idaho State Medical Association accredited sponsor, and designates this educational activity for a maximum of 3.5 hours of AMA PRA Category Credit. Physicians should only claim credit commensurate with the extent of their participation in the activity.
We would like to thank the support of the following partners/sponsors/exhibitors:
Lynda Irish, M.Ed.